Source:http://linkedlifedata.com/resource/pubmed/id/11123896
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
51
|
pubmed:dateCreated |
2001-1-8
|
pubmed:abstractText |
Protein C inhibitor, a serine proteinase inhibitor (serpin), is the physiologically most important inhibitor of activated protein C. We have made a monoclonal antibody (M36) that binds with equally high affinity to an epitope present in activated protein C-protein C inhibitor complexes and cleaved loop-inserted protein C inhibitor. Insertion of a synthetic N-acetylated tetradecapeptide (corresponding to residues P1-P14 of the reactive center loop) into beta-sheet A of the uncleaved inhibitor also exposed the epitope. The antibody had no apparent affinity for native uncleaved inhibitor or for the free peptide. Synthetic P1-P14 analogues, with Arg P13 or Ala P9 substituted to the residues found in mouse protein C inhibitor (Thr and Ile, respectively), were also inserted in beta-sheet A. The Arg P13/Thr substitution led to a greatly impaired reactivity with the antibody, whereas the Ala P9/Ile mutation resulted in a modest loss of reactivity with the antibody. These results indicate that complex formation leads to insertion of the reactive center loop in beta-sheet A from Arg P14 and presumably beyond Ala P9. Moreover, to the best of our knowledge, this is the first instance where the neoepitope of a complexation-specific monoclonal antibody has been localized to the loop-inserted part of beta-sheet A, the part of the serpin where the complexation-induced conformational change is most conspicuous.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Epitopes,
http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments,
http://linkedlifedata.com/resource/pubmed/chemical/Protein C,
http://linkedlifedata.com/resource/pubmed/chemical/Protein C Inhibitor
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0006-2960
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
26
|
pubmed:volume |
39
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
15713-20
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11123896-Animals,
pubmed-meshheading:11123896-Antibodies, Monoclonal,
pubmed-meshheading:11123896-Antibody Specificity,
pubmed-meshheading:11123896-Binding Sites,
pubmed-meshheading:11123896-Computer Simulation,
pubmed-meshheading:11123896-Enzyme Activation,
pubmed-meshheading:11123896-Epitopes,
pubmed-meshheading:11123896-Humans,
pubmed-meshheading:11123896-Mice,
pubmed-meshheading:11123896-Models, Molecular,
pubmed-meshheading:11123896-Peptide Fragments,
pubmed-meshheading:11123896-Protein C,
pubmed-meshheading:11123896-Protein C Inhibitor,
pubmed-meshheading:11123896-Protein Conformation,
pubmed-meshheading:11123896-Protein Structure, Secondary,
pubmed-meshheading:11123896-Structure-Activity Relationship
|
pubmed:year |
2000
|
pubmed:articleTitle |
Activated protein C-protein C inhibitor complex formation: characterization of a neoepitope provides evidence for extensive insertion of the reactive center loop.
|
pubmed:affiliation |
Department of Clinical Chemistry, University Hospital, Malmö, Lund University, S-205 Malmö, Sweden.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|